Loading company…
Nereid Therapeutics develops technologies to measure and modify liquid-liquid phase separation in cells.
Nereid Therapeutics develops technologies to measure and modulate liquid-liquid phase separation in mammalian cells, supporting drug discovery for diseases including cancer and neurodegenerative disorders. Founded in 2020 and based in Boston, US, it raised USD 50 mn in Seed funding led by Apple Tree Partners on November 16, 2020. Spiros Liras is the founder and Michael Kauffman is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in